Altenschmidt U - Search Results

1

Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells.

Maurer-Gebhard M, Schmidt M, Azemar M, Altenschmidt U, Stöcklin E, Wels W, Groner B. Maurer-Gebhard M, et al. Among authors: altenschmidt u. Cancer Res. 1998 Jun 15;58(12):2661-6. Cancer Res. 1998. PMID: 9635594

2

Targeted therapy of schwannoma cells in immunocompetent rats with an erbB2-specific antibody-toxin.

Altenschmidt U, Schmidt M, Groner B, Wels W. Altenschmidt U, et al. Int J Cancer. 1997 Sep 26;73(1):117-24. doi: 10.1002/(sici)1097-0215(19970926)73:1<117::aid-ijc18>3.0.co;2-d. Int J Cancer. 1997. PMID: 9334818

3

Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.

Altenschmidt U, Kahl R, Moritz D, Schnierle BS, Gerstmayer B, Wels W, Groner B. Altenschmidt U, et al. Clin Cancer Res. 1996 Jun;2(6):1001-8. Clin Cancer Res. 1996. PMID: 9816261

4

Schwannoma cells induce a tumor-cell-specific cytotoxic-T-cell response upon transplantation into syngeneic rats but escape elimination through the secretion of immunosuppressive factors.

Altenschmidt U, Kahl R, Klundt E, Stöcklin E, Mihatsch M, Weindel K, Groner B. Altenschmidt U, et al. Int J Cancer. 1997 Mar 4;70(5):542-50. doi: 10.1002/(sici)1097-0215(19970304)70:5<542::aid-ijc9>3.0.co;2-y. Int J Cancer. 1997. PMID: 9052753

5

Specific cytotoxic T lymphocytes in gene therapy.

Altenschmidt U, Moritz D, Groner B. Altenschmidt U, et al. J Mol Med (Berl). 1997 Apr;75(4):259-66. doi: 10.1007/s001090050111. J Mol Med (Berl). 1997. PMID: 9151212 Review.

6

Costimulation of T-cell proliferation by a chimeric B7-antibody fusion protein.

Gerstmayer B, Hoffmann M, Altenschmidt U, Wels W. Gerstmayer B, et al. Among authors: altenschmidt u. Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):156-8. doi: 10.1007/s002620050421. Cancer Immunol Immunother. 1997. PMID: 9435862 Free PMC article.

7

Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression.

Altenschmidt U, Klundt E, Groner B. Altenschmidt U, et al. J Immunol. 1997 Dec 1;159(11):5509-15. J Immunol. 1997. PMID: 9548491

8

Direction of the recognition specificity of cytotoxic T cells toward tumor cells by transduced, chimeric T-cell receptor genes.

Maurer-Gebhard M, Azémar M, Altenschmidt U, Humar M, Groner B. Maurer-Gebhard M, et al. Among authors: altenschmidt u. Methods Mol Med. 2001;39:749-56. doi: 10.1385/1-59259-071-3:749. Methods Mol Med. 2001. PMID: 21340836

9

Costimulation of T cell proliferation by a chimeric B7-2 antibody fusion protein specifically targeted to cells expressing the erbB2 proto-oncogene.

Gerstmayer B, Altenschmidt U, Hoffmann M, Wels W. Gerstmayer B, et al. Among authors: altenschmidt u. J Immunol. 1997 May 15;158(10):4584-90. J Immunol. 1997. PMID: 9144470

10

pH-sensitive liposomes for receptor-mediated delivery to chicken hepatoma (LMH) cells.

Skalko N, Peschka R, Altenschmidt U, Lung A, Schubert R. Skalko N, et al. Among authors: altenschmidt u. FEBS Lett. 1998 Sep 4;434(3):351-6. doi: 10.1016/s0014-5793(98)00984-3. FEBS Lett. 1998. PMID: 9742953 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters